Roche said it will run a new Phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in another attempt to win approval for the therapy in Europe and other regions.
The
The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to “thousands” of young people this summer.
Amid the push to digitise the UK health service, a study has sounded a note of caution about entrusting important patient appointments to chatbots.
Novo Nordisk has become the latest pharma group to be targeted by a cyberattack, confirming a breach exposed some patient data.
Audio is becoming an increasingly important area of focus in pharma marketing, and now four big drugmakers have become sponsors for a new podcast focusing
Novo Nordisk’s fast-growing Wegovy pill has been approved in the UK for weight loss, its first European market.
Roche said it will run a new Phase 3 trial for the controversial Duchenne muscular dystrophy gene therapy Elevidys in another attempt to win approval for the therapy in Europe and other regions.
The